Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer

Coscia, F.
Lengyel, E.
Duraiswamy, J.
Ashcroft, B.
Bassani-Sternberg, M.
Wierer, M.
Johnson, A.
Wroblewski, K.
Montag, A.
Yamada, S.D.
López-Méndez, B.
Nilsson, J.
Mund, A.
Mann, M.
Curtis, M.

September 2018

Most high-grade serous ovarian cancer (HGSOC) patients develop resistance to platinum-based chemothe...

DataSheet1_NOP58 induction potentiates chemoresistance of colorectal cancer cells through aerobic glycolysis as evidenced by proteomics analysis.zip

Feifei Wang (195514)
Bin Yu (14464)
Quanyong Yu (2853107)
Guanglin Wang (1634146)
Baokun Li (12910682)
Ganlin Guo (17620230)
Handong Wang (9913932)
Hui Shen (66625)
Shujin Li (313783)
Chunling Ma (313780)
Xianxian Jia (11770010)
Guiying Wang (153514)
Bin Cong (313785)

December 2023

Introduction: The majority of individuals diagnosed with advanced colorectal cancer (CRC) will ultim...

Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer.

Nibbe, Rod K.
Markowitz, Sanford
Myeroff, Lois
Ewing, Rob
Chance, Mark R.

April 2009

We used a systems biology approach to identify and score protein interaction subnetworks whose activ...

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Teresa Núñez de Villavicencio-Díaz
Yassel Ramos Gómez
Brizaida Oliva Argüelles
Julio R. Fernández Masso
Arielis Rodríguez-Ulloa
Yiliam Cruz García
Osmany Guirola-Cruz
Yasset Perez-Riverol
Luis Javier González
Inés Tiscornia
Sabina Victoria
Mariela Bollati-Fogolín
Vladimir Besada Pérez
Maribel Guerra Vallespi

September 2015

CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colo...

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Núñez de Villavicencio-Díaz, Teresa
Ramos Gómez, Yassel
Oliva Argüelles, Brizaida
Fernández Masso, Julio R.
Rodríguez-Ulloa, Arielis
Cruz García, Yiliam
Guirola-Cruz, Osmany
Perez-Riverol, Yasset
Javier González, Luis
Tiscornia, Inés
Victoria, Sabina
Bollati-Fogolín, Mariela
Besada Pérez, Vladimir
Guerra Vallespi, Maribel

September 2015

AbstractCIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung ...

Proteomic Study to Survey the CIGB-552 Antitumor Effect

Arielis Rodríguez-Ulloa
Jeovanis Gil
Yassel Ramos
Lilian Hernández-Álvarez
Lisandra Flores
Brizaida Oliva
Dayana García
Aniel Sánchez-Puente
Alexis Musacchio-Lasa
Jorge Fernández-de-Cossio
Gabriel Padrón
Luis J. González López
Vladimir Besada
Maribel Guerra-Vallespí

January 2015

CIGB-552 is a cell-penetrating peptide that exerts in vitro and in vivo antitumor effect on cancer c...

Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552

Astrada, Soledad
Gomez, Yolanda
Barrera Guisasola, Exequiel Ernesto
Obal, Gonzalo
Pritsch, Otto
Pantano, Sergio
Vallespí, Maribel G.
Bollati Fogolín, Mariela

November 2016

Because of resistance development by cancer cells against current anticancer drugs, there is a consi...

An Integrated Proteomics and Bioinformatics Analysis of the Anticancer Properties of RT2 Antimicrobial Peptide on Human Colon Cancer (Caco-2) Cells

Surachai Maijaroen
Sompong Klaynongsruang
Sittiruk Roytrakul
Monruedee Konkchaiyaphum
Lapatrada Taemaitree
Nisachon Jangpromma

February 2022

New selective, efficacious chemotherapy agents are in demand as traditional drugs display side effec...

Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models

Vallespi, M.G.
Pimentel, G.
Cabrales-Rico, A.
Garza, J.
Oliva, B.
Mendoza, O.
Gomez, Y.
Basaco, T.
Sanchez, I.
Calderon, C.
Rodriguez, J.C.
Markelova, M.R.
Fichtner, I.
Astrada, S.
Bollati-Fogolín, M.
Garay, H.E.
Reyes, O.

November 2014

Accumulation of the COMMD1 protein as a druggable pharmacology event to target cancer cells has not ...

Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity

Soledad Astrada
Julio Raúl Fernández Massó
Maribel G. Vallespí
Mariela Bollati-Fogolín

March 2018

CIGB-552 is a twenty-amino-acid novel synthetic peptide that has proven to be effective in reducing ...

Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion

Hui-Fang Hu (4575982)
Wen Wen Xu (836360)
Yang Wang (5921)
Can-Can Zheng (4575979)
Wei-Xia Zhang (4575985)
Bin Li (39349)
Qing-Yu He (240828)

October 2017

Metastasis is one of the major causes of treatment failure in the patients with colon cancer. The ai...

Proteomic study of β-catenin protein interactions in colon cancer

Semaan, Crystal

Empirical thesis.Running title: Proteomic study of β-catenin protein interactions in colon cancer.Bi...

Research Article

Mariela Bollati-fogolín
Maribel G. Vallespí

September 2016

The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines

Stéfano M. Cirigliano
María I. Díaz Bessone
Damián E. Berardi
Carolina Flumian
Elisa D. Bal de Kier Joffé
Silvio E. Perea
Hernán G. Farina
Laura B. Todaro
Alejandro J. Urtreger

March 2017

Abstract Background Lung cancer is the most frequently diagnosed cancer and the leading cause of can...

DataSheet2_NOP58 induction potentiates chemoresistance of colorectal cancer cells through aerobic glycolysis as evidenced by proteomics analysis.zip

Feifei Wang (195514)
Bin Yu (14464)
Quanyong Yu (2853107)
Guanglin Wang (1634146)
Baokun Li (12910682)
Ganlin Guo (17620230)
Handong Wang (9913932)
Hui Shen (66625)
Shujin Li (313783)
Chunling Ma (313780)
Xianxian Jia (11770010)
Guiying Wang (153514)
Bin Cong (313785)

December 2023

Introduction: The majority of individuals diagnosed with advanced colorectal cancer (CRC) will ultim...

Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer

Coscia, F.
Lengyel, E.
Duraiswamy, J.
Ashcroft, B.
Bassani-Sternberg, M.
Wierer, M.
Johnson, A.
Wroblewski, K.
Montag, A.
Yamada, S.D.
López-Méndez, B.
Nilsson, J.
Mund, A.
Mann, M.
Curtis, M.

September 2018

Most high-grade serous ovarian cancer (HGSOC) patients develop resistance to platinum-based chemothe...

DataSheet1_NOP58 induction potentiates chemoresistance of colorectal cancer cells through aerobic glycolysis as evidenced by proteomics analysis.zip

Feifei Wang (195514)
Bin Yu (14464)
Quanyong Yu (2853107)
Guanglin Wang (1634146)
Baokun Li (12910682)
Ganlin Guo (17620230)
Handong Wang (9913932)
Hui Shen (66625)
Shujin Li (313783)
Chunling Ma (313780)
Xianxian Jia (11770010)
Guiying Wang (153514)
Bin Cong (313785)

December 2023

Introduction: The majority of individuals diagnosed with advanced colorectal cancer (CRC) will ultim...

Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer.

Nibbe, Rod K.
Markowitz, Sanford
Myeroff, Lois
Ewing, Rob
Chance, Mark R.

April 2009

We used a systems biology approach to identify and score protein interaction subnetworks whose activ...

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Teresa Núñez de Villavicencio-Díaz
Yassel Ramos Gómez
Brizaida Oliva Argüelles
Julio R. Fernández Masso
Arielis Rodríguez-Ulloa
Yiliam Cruz García
Osmany Guirola-Cruz
Yasset Perez-Riverol
Luis Javier González
Inés Tiscornia
Sabina Victoria
Mariela Bollati-Fogolín
Vladimir Besada Pérez
Maribel Guerra Vallespi

September 2015

CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colo...

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Núñez de Villavicencio-Díaz, Teresa
Ramos Gómez, Yassel
Oliva Argüelles, Brizaida
Fernández Masso, Julio R.
Rodríguez-Ulloa, Arielis
Cruz García, Yiliam
Guirola-Cruz, Osmany
Perez-Riverol, Yasset
Javier González, Luis
Tiscornia, Inés
Victoria, Sabina
Bollati-Fogolín, Mariela
Besada Pérez, Vladimir
Guerra Vallespi, Maribel

September 2015

AbstractCIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung ...

Proteomic Study to Survey the CIGB-552 Antitumor Effect

Arielis Rodríguez-Ulloa
Jeovanis Gil
Yassel Ramos
Lilian Hernández-Álvarez
Lisandra Flores
Brizaida Oliva
Dayana García
Aniel Sánchez-Puente
Alexis Musacchio-Lasa
Jorge Fernández-de-Cossio
Gabriel Padrón
Luis J. González López
Vladimir Besada
Maribel Guerra-Vallespí

January 2015

CIGB-552 is a cell-penetrating peptide that exerts in vitro and in vivo antitumor effect on cancer c...

Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552

Astrada, Soledad
Gomez, Yolanda
Barrera Guisasola, Exequiel Ernesto
Obal, Gonzalo
Pritsch, Otto
Pantano, Sergio
Vallespí, Maribel G.
Bollati Fogolín, Mariela

November 2016

Because of resistance development by cancer cells against current anticancer drugs, there is a consi...

An Integrated Proteomics and Bioinformatics Analysis of the Anticancer Properties of RT2 Antimicrobial Peptide on Human Colon Cancer (Caco-2) Cells

Surachai Maijaroen
Sompong Klaynongsruang
Sittiruk Roytrakul
Monruedee Konkchaiyaphum
Lapatrada Taemaitree
Nisachon Jangpromma

February 2022

New selective, efficacious chemotherapy agents are in demand as traditional drugs display side effec...

Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models

Vallespi, M.G.
Pimentel, G.
Cabrales-Rico, A.
Garza, J.
Oliva, B.
Mendoza, O.
Gomez, Y.
Basaco, T.
Sanchez, I.
Calderon, C.
Rodriguez, J.C.
Markelova, M.R.
Fichtner, I.
Astrada, S.
Bollati-Fogolín, M.
Garay, H.E.
Reyes, O.

November 2014

Accumulation of the COMMD1 protein as a druggable pharmacology event to target cancer cells has not ...

Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity

Soledad Astrada
Julio Raúl Fernández Massó
Maribel G. Vallespí
Mariela Bollati-Fogolín

March 2018

CIGB-552 is a twenty-amino-acid novel synthetic peptide that has proven to be effective in reducing ...

Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion

Hui-Fang Hu (4575982)
Wen Wen Xu (836360)
Yang Wang (5921)
Can-Can Zheng (4575979)
Wei-Xia Zhang (4575985)
Bin Li (39349)
Qing-Yu He (240828)

October 2017

Metastasis is one of the major causes of treatment failure in the patients with colon cancer. The ai...

Proteomic study of β-catenin protein interactions in colon cancer

Semaan, Crystal

Empirical thesis.Running title: Proteomic study of β-catenin protein interactions in colon cancer.Bi...

Research Article

Mariela Bollati-fogolín
Maribel G. Vallespí

September 2016

The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines

Stéfano M. Cirigliano
María I. Díaz Bessone
Damián E. Berardi
Carolina Flumian
Elisa D. Bal de Kier Joffé
Silvio E. Perea
Hernán G. Farina
Laura B. Todaro
Alejandro J. Urtreger

March 2017

Abstract Background Lung cancer is the most frequently diagnosed cancer and the leading cause of can...

DataSheet2_NOP58 induction potentiates chemoresistance of colorectal cancer cells through aerobic glycolysis as evidenced by proteomics analysis.zip

Feifei Wang (195514)
Bin Yu (14464)
Quanyong Yu (2853107)
Guanglin Wang (1634146)
Baokun Li (12910682)
Ganlin Guo (17620230)
Handong Wang (9913932)
Hui Shen (66625)
Shujin Li (313783)
Chunling Ma (313780)
Xianxian Jia (11770010)
Guiying Wang (153514)
Bin Cong (313785)

December 2023

Introduction: The majority of individuals diagnosed with advanced colorectal cancer (CRC) will ultim...

Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer

Coscia, F.
Lengyel, E.
Duraiswamy, J.
Ashcroft, B.
Bassani-Sternberg, M.
Wierer, M.
Johnson, A.
Wroblewski, K.
Montag, A.
Yamada, S.D.
López-Méndez, B.
Nilsson, J.
Mund, A.
Mann, M.
Curtis, M.

September 2018

Most high-grade serous ovarian cancer (HGSOC) patients develop resistance to platinum-based chemothe...

DataSheet1_NOP58 induction potentiates chemoresistance of colorectal cancer cells through aerobic glycolysis as evidenced by proteomics analysis.zip

Feifei Wang (195514)
Bin Yu (14464)
Quanyong Yu (2853107)
Guanglin Wang (1634146)
Baokun Li (12910682)
Ganlin Guo (17620230)
Handong Wang (9913932)
Hui Shen (66625)
Shujin Li (313783)
Chunling Ma (313780)
Xianxian Jia (11770010)
Guiying Wang (153514)
Bin Cong (313785)

December 2023

Introduction: The majority of individuals diagnosed with advanced colorectal cancer (CRC) will ultim...

Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer.

Nibbe, Rod K.
Markowitz, Sanford
Myeroff, Lois
Ewing, Rob
Chance, Mark R.

April 2009

We used a systems biology approach to identify and score protein interaction subnetworks whose activ...

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Abstract

Extracted data

Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

Abstract

Extracted data

Related items

Related items